News - CIMIT MAIN

NIH LIVE QA

NIH LIVE QA Session RADX Delivering new COVID-19 Testing Tech to Meet US Demand Watch Dr. Francis Collins, NIH Director, and Dr. Bruce Tromberg, NIBIB Director discuss the first seven technologies contracted with the NIH RADx program. Watch Now >   Read MoreAboutNIH LIVE QA »

NIH delivering new COVID-19 testing technologies to meet U.S. demand

NIH delivering new COVID-19 testing technologies to meet U.S. demand Range of new technologies will meet testing needs in diverse settings The National Institutes of Health is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of tests by millions per week as early as September 2020. With national demand estimated to be millions more tests per day above current levels, these technologies are expected to make a significant contribution to expanding the nation’s testing capacity. “RADx moved incredibly quickly to select promising technologies through its ‘shark tank’ approach, investing in technologies that could boost America’s best-in-the-world COVID-19 testing capacity by millions more tests per day,” said HHS Secretary Alex Azar. “These technologies will help deliver faster results from labs and more and more test results within minutes at the point of care, which is especially important for settings like schools and nursing homes.” Read the full release >   Read MoreAboutNIH delivering new COVID-19 testing technologies to meet U.S. demand »

PathogenDx Receives Federal Grant From the NIH As Part of the RADx Program

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative The capital will be used to scale up testing capacity of PathogenDx's Microarray Assay for COVID-19 testing nationally SCOTTSDALE, Ariz., July 28, 2020 /PRNewswire/ --  PathogenDx , Inc., an Arizona based technology company which has developed an ultra-accurate DNA-based customized pathogen testing platform for the food, agricultural and health sectors, announced today that the company has been awarded a federal grant from the National Institutes of Health (NIH) under their Rapid Acceleration of Diagnostic (RADx) program. The resources will be used to increase the testing capacity of PathogenDx's DetectX-Rv Microarray Assay for COVID-19 testing to a national level. Read the full release here > Read MoreAboutPathogenDx Receives Federal Grant From the NIH As Part of the RADx Program »

RADx Tech COVID19 Webinar Series: Regulatory Affairs on the RADx Frontlines

RADx Tech COVID19 Webinar Series: Regulatory Affairs on the RADx Frontlines Perspective from a Point-of-Care Technology Research Center Join us for a webinar discussing the lessons we've learned to date from Regulatory experts during the COVID-19 pandemic. Speaker: Erika Tyburski Director of Operations, Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME-POCT) When: August 4, 2020, 2:00PM ET Register by August 2, 2020  > Read MoreAboutRADx Tech COVID19 Webinar Series: Regulatory Affairs on the RADx Frontlines »

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative The first reports of an unusual cluster of pneumonia cases in the city of Wuhan, China, emerged in December 2019, heralding a global pandemic. As of July 13, 2020, more than 3.3 million U.S. residents have received a diagnosis of coronavirus disease 2019 (Covid-19), and more than 135,000 have died. Of great concern are the data showing the disproportionate effect of Covid-19 on ethnic and racial minorities. Since January 2020, the National Institutes of Health (NIH) has been involved in multiple wide-ranging collaborative efforts spanning the development of vaccines and diagnostic strategies, the identification and evaluation of safe and effective treatments, the understanding of the natural history of the disease, and the study of racial and ethnic disparities. In this article, we describe the additional role of the NIH in the effort to increase the range and availability of diagnostic tests for the causative virus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Read the full NEJM article > Read MoreAboutRapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative »

RADx Tech COVID19 Webinar Series: User Centered Design for the Rapid Acceleration of Diagnostics

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds... User Centered Design for the Rapid Acceleration of Diagnostics for COVID19 This webinar discusses the lessons we've learned so far during the COVID19 pandemic and what questions still remain. Join us for a webinar discussing how the practice of design thinking can be leveraged to accelerate the innovation pipeline of technology and deploy them to meet today's most pressing health needs. Speaker: Andrew J. DiMeo, Sr., Ph.D. Founder and CEO of CanvasGT, Inc. Innovation & Design Coach for Trig Former Professor of the Practice at the UNC and NC State Joint Department of Biomedical Engineering When: July 21, 2020, 2:00PM EDT View the Recording > Password:  !tzz*L5g Read MoreAboutRADx Tech COVID19 Webinar Series: User Centered Design for the Rapid Acceleration of Diagnostics »

Group Aims to Test the Safety of DIY Medical Supplies for COVID-19

Group Aims to Test the Safety of DIY Medical Supplies for COVID-19 With many novel designs emerging to address the shortages of medical supplies, there remains a need to vet the devices and ensure safety standards are met As workers on the front lines of the COVID-19 pandemic struggle to find adequate medical supplies and protective gear, innovators from around the world have rallied to create new designs from readily available materials. These include 3D-printed  face shields  and  nasal swabs , plus  ventilator machines  and an  open-source oxygen concentrator . While the response from these well-intentioned innovators is inspiring, there remains some issues around the use these new designs—one in particular being that very few were designed to meet minimum safety standards or vetted at an early enough stage to help these pop-up equipment manufacturers make the necessary adjustments. Read More > Read MoreAboutGroup Aims to Test the Safety of DIY Medical Supplies for COVID-19 »

3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19

3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19 The goal is a new, highly accurate, mass-produced low-cost diagnostic device that delivers results in minutes. ST. PAUL, Minn.--( BUSINESS WIRE )--To help the world respond to COVID-19, 3M and researchers at MIT are testing a new rapid test that detects the virus. Accelerated research is underway to learn if a simple-to-use, diagnostic device can produce highly accurate results within minutes and is feasible to mass manufacture. The U.S. National Institute of Health selected the rapid COVID-19 test for accelerated development and commercialization support, after rigorous review by an expert panel. The test is in the Rapid Acceleration of Diagnostics Tech (RADx Tech) program, an aggressively-paced COVID-19 diagnostics initiative from the NIH’s National Institute of Biomedical Imaging and Bioengineering. Read the full release > Read MoreAbout3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19 »

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds... The Challenges of COVID-19 / SARS-CoV-2 Diagnostics This webinar discusses the lessons we've learned so far during the COVID19 pandemic and what questions still remain. Speaker: Yukari Manabe, MD Principal Investigator, JHU Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases Professor of Medicine in the Division of Infectious Diseases, Associate Director of Global Health Research and Innovation, Johns Hopkins University School of Medicine When: This webinar took place July 7, 2020, 2:00PM EDT View the Recording Read MoreAboutRADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds »

7 Tips from Boston for Healthtech Entrepreneurs

7 Tips from Boston for Healthtech Entrepreneurs Who will pay for my product? Who can kill it? How do I approach investors? What happens if I fail? Experts from CIMIT (Boston), the most experienced health accelerator in the world, share some of the lessons they’ve learned accelerating more than 600 healthtech projects in 15 years. CIMIT ,  based in Boston, is the  most experienced health accelerator in the world : over 15 years, they have  successfully accelerated  more than 600 healthtech projects, doubling their rate of commercialization. The  team  is made up of veteran entrepreneurs and executives from the sector with extensive careers packed with personal successes (and failures, too, to learn from). Seven of these experts traveled to Barcelona this April to kick off the mentoring for the  projects selected  for  CRAASH Barcelona , Biocat’s new acceleration program, and  gave a talk  summing up some of the lessons they’ve learned over the course of their careers. Read More > Read MoreAbout7 Tips from Boston for Healthtech Entrepreneurs »

Healthcare Innovation Methodology: Codifying the Process of Translating Knowledge into Better Healthcare Products, Services, and Procedures

Healthcare Innovation Methodology: Codifying the Process of Translating Knowledge into Better Healthcare Products, Services, and Procedures Much effort and funding has gone into defining and improving the process of creating scientific and medical knowledge that will improve healthcare. However, comparatively little has been published on the equally important topic of turning that knowledge into products, services, and procedures that actually improve health outcomes, that is, ‘healthcare innovation.’ The authors provide an overview of the differences between research and innovation and discuss why treating them as distinct processes is important to help maximize the successful translation of research into population health benefits. Based on the available literature, along with the study of more than 1000 projects, a framework is provided that codifies the process of innovation in healthcare and, therefore, is able to study, improve, and teach the process. Read more > Read MoreAboutHealthcare Innovation Methodology: Codifying the Process of Translating Knowledge into Better Healthcare Products, Services, and Procedures »

7 Medtech Ideas Out of Europe

7 Medtech Ideas Out of Europe Mobile and digital health ideas — and overall medtech innovation ideas — abound in Europe, with DeviceTalks Boston attendees getting just a sampling this morning from seven CRAASH Barcelona participants. The  CRAASH Barcelona  program trains research projects on how to market their health technologies during a three- to five-year period. It’s a boot camp run by   EIT Health , the main European healthcare consortium, and organized by Biocat in collaboration with  CIMIT  (Boston).  Read More > Read MoreAbout7 Medtech Ideas Out of Europe »

Space Health Institute Awards $1.5M for Medical Innovations

Space Health Institute Awards $1.5M for Medical Innovations The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine has partnered with Consortia for Improving Medicine with Innovation and Technology (CIMIT) to grant $1.5 million in awards to nine companies researching medical technologies for preserving astronaut health in space exploration. These nine companies will advance their biomedical research into technologies for predicting and protecting astronaut health. Research topics include lab tests for use in space, multi-parameter health assessment and health surveillance systems, and onboard manufacturing of active ingredients for medication. Read More > Read MoreAboutSpace Health Institute Awards $1.5M for Medical Innovations »

PhotoniCare Looks Behind Ear Drums to Help Diagnose Ear Infections

PhotoniCare Looks Behind Ear Drums to Help Diagnose Ear Infections PhotoniCare’s TOMi Scope uses near-infrared light waves to provide 3D views beyond the ear drum into the middle ear, allowing physicians to visualize and better diagnose middle ear infections. Middle ear infections are one of the most common reasons for visits to the pediatrician. However, because the middle ear is hidden from view by the ear drum, physicians must diagnose based on symptoms and a limited physical exam — and when patients have ambiguous or borderline symptoms, accurate diagnosis can be challenging. Read More > Read MoreAboutPhotoniCare Looks Behind Ear Drums to Help Diagnose Ear Infections »

Preventing Innovators From Falling At The Next Hurdle

Preventing Innovators From Falling At The Next Hurdle Jorge‑Fernandez Garcia, EIT Health Director of Innovation, and John Collins, Chief Operating Officer of CIMIT, discuss approaches that can lead to successful healthcare innovation Innovation has the potential to change the face of Europe. It has the potential to improve the way we live, the way we plan for the future, and the way we thrive as a continent (both politically and economically). In order to innovate effectively, however, crucial building blocks must be in place. EIT Health seeks to contribute towards a stronger health ecosystem in Europe by overcoming fragmentation, increasing efficiency and breaking down barriers to innovation in healthcare. What does this mean? It means that all parts of the innovation puzzle should work together effectively, across borders. In Europe, there are often barriers to this vision of cooperation: we don’t speak the same languages (literally and figuratively), each country has their own individual health systems, and we can often be quite locally-minded, so that innovation isn’t easily shared across the continent. We need to overcome this fragmentation if we want to address the challenges that exist, increase efficiency and break down barriers. While we seek to develop a unified, efficient system, we also must support individual innovators in navigating the current fragmentation. Read More >> Read MoreAboutPreventing Innovators From Falling At The Next Hurdle »

COVID Survey

Important COVID-19 Survey Please complete the survey below as soon as possible - within the next few days if possible. There are many urgent unmet medical needs surrounding the diagnosis and treatment of COVID-19. As the Coordinating Center for the NIH-sponsored Point-of-Care Technology Research Network, we are now reaching out to you and other stakeholders to determine how POCTRN can best support nation-wide efforts to enhance the diagnosis and treatment of patients with COVID-19 infection. Please complete the survey below as soon as possible - within the next few days if possible. Complete the Survey   Read MoreAboutCOVID Survey »

Space Health Institute Awards Grants to Three Innovative Small Companies

The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine has partnered with the Consortia for Improving Medicine with Innovation and Technology (CIMIT) to award three companies that will perform research related to artificial intelligence and point-of-care diagnostics. Read MoreAboutSpace Health Institute Awards Grants to Three Innovative Small Companies »

Space Health Institute Awards $1.5M for Medical Innovations

The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine has partnered with Consortia for Improving Medicine with Innovation and Technology (CIMIT) to grant $1.5 million in awards to nine companies researching medical technologies for preserving astronaut health in space exploration. Read MoreAboutSpace Health Institute Awards $1.5M for Medical Innovations »

Can your research help avoid the call "Houston we have a problem"?!?

A year and a half ago, the Translational Research Institute for Space Health (TRISH) was stood up with the imperative purpose of funding radical, disruptive science and technologies that could be translated to protect and optimize human health and performance during long-duration, deep space exploration missions. Read MoreAboutCan your research help avoid the call "Houston we have a problem"?!? »

Jana Care and Massachusetts General Hospital kick off study to evaluate mobile app for heart failure management funded by CIMIT

Medical technology company Jana Care announced that it is collaborating with Massachusetts General Hospital (MGH) to study the effectiveness of a mobile application (app) for the self-management of congestive heart failure. Recruitment of heart failure patients at MGH has just begun, and the study is expected to conclude by the end of 2017. The study is being funded by a grant from the Consortia for Improving Medicine with Innovation and Technology (CIMIT) through their Point-of-Care Technologies Research Network (POCTRN) program. Read MoreAboutJana Care and Massachusetts General Hospital kick off study to evaluate mobile app for heart failure management funded by CIMIT »